VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CCAP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CCAPCrescent Capital BDC, Inc.
$9.38$346M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCCAPBalance Sheet

Crescent Capital BDC, Inc. (CCAP) Balance Sheet

11Y historyFree accessUpdated daily

Against a flat ~$1.6B asset base, equity declined 12.7% to $656.5M while liabilities expanded 10.8% to $962.4M, compressing equity-to-assets from 0.46 to 0.41 and leaving only $15.6M of cash against the liability stack — roughly 1.6% coverage that may indicate liquidity dependence on portfolio maturities.

Income StatementBalance SheetCash FlowRatios

CCAP Balance Sheet

Annual statement

CCAP Balance Sheet

Crescent Capital BDC, Inc. (CCAP) balance sheet — 11-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Cash & Short Term Investments80.63M5.04M10.13M7.78M6.4M10.07M1.9M4.58M9.81M8.79M5.12M4.77M
Cash & Due from Banks15.6M5.04M10.13M7.78M6.4M10.07M1.9M4.58M10.37M9.27M5.12M4.77M
Short Term Investments00000000559.01K-479.13K00
Total Investments1.57B2.13M1.6B1.59B1.26B1.27B1.03B726.53M493.92M319.13M217.92M138.07M
Investments Growth %36723.31%-99.87%0.73%25.67%-0.58%22.86%42.32%47.1%54.77%46.44%57.84%-
Long-Term Investments3.11B2.13M1.6B1.59B1.26B1.27B1.03B726.53M493.36M319.13M217.92M138.07M
Accounts Receivables0012.17M14.25M9.95M21.63M3.87M2.99M002.47M429.61K
Goodwill & Intangibles000114K0000299.47K000
Goodwill000114K0000299.47K000
Intangible Assets000000000000
PP&E (Net)00000000-505.72M000
Other Assets01.61B1.01M-228K4.75M168K1.17M3.47M559.01K-329.82M-225.56M0
Total Current Assets23.82M5.04M56.41M22.03M35.17M47.27M18.98M17.18M11.18M10.13T7.64M5.25M
Total Non-Current Assets1.57B1.62B1.6B1.59B1.27B1.27B1.04B730M493.92M319.13M217.92M138.07M
Total Assets1.62B1.62B1.66B1.63B1.3B1.32B1.05B747.17M505.12M329.82M225.56M143.32M
Asset Growth %-8.2%-2.06%1.78%24.91%-1.13%25.01%41.09%47.92%53.15%46.22%57.38%-
Return on Assets (ROA)-0.2%2.11%4.49%5.72%1.19%7.05%6.07%4.68%1.94%3.26%6.38%-1.5%
Accounts Payable027.9M026.09M514K0007.49M3.73M09.18M
Total Debt922.95M873.76M875.84M844.78M654.46M631.04M471.93M322.01M235.71M150.85M52.75K54.49M
Net Debt907.34M868.72M865.71M837M648.06M620.97M470.04M317.43M225.34M141.58M-5.07M49.73M
Long-Term Debt922.95M873.76M875.84M844.78M654.46M631.04M471.93M322.01M235.71M150.85M93.67M54.49M
Short-Term Debt000000000000
Other Liabilities05.93M746K-845.36M1.06M1.59M2.22M944K-235.71M-150.85M-93.67M0
Total Current Liabilities20.3M36.4M39.05M26.09M34.83M32.9M20M17.3M10.13M6.17M3.84M11.24M
Total Non-Current Liabilities923.17M879.7M876.58M844.78M655.51M632.63M474.15M322.95M235.71M150.85M93.67M54.49M
Total Liabilities962.44M916.1M915.64M884.78M690.34M665.52M494.15M340.26M245.54M157.02M6.38K65.73M
Total Equity656.45M706.04M740.64M742.59M612.54M652.28M560M406.92M484.92M314.38M314.12M77.59M
Equity Growth %-26.03%-4.67%-0.26%21.23%-6.09%16.48%37.62%-16.09%54.25%0.08%304.86%-
Equity / Assets (Capital Ratio)40.55%43.53%44.72%45.63%47.01%49.5%53.12%54.46%96%95.32%139.26%54.13%
Return on Equity (ROE)-0.46%4.77%9.93%12.37%2.46%13.8%11.31%6.57%2.03%2.88%6.01%-2.78%
Book Value per Share17.8119.0619.9820.6719.8322.9120.2314.4716.1410.4748.9530.09
Tangible BV per Share17.8119.0619.9820.6719.8322.9120.2314.4716.1310.4748.9530.09
Common Stock37K37K37K37K31K31K28K21K13.36K8.6K6.38K4.06K
Additional Paid-in Capital955.36M957.03M959.1M965.89M675.01M666.16M594.66M414.29M266.02M170.76M125.75M80.81M
Retained Earnings-298.95M-251.03M-218.5M-223.34M-62.5M-13.91M-34.69M-7.4M-6.46M2.04M128.06M-3.23M
Accumulated OCI00000000259.58M172.8M128.06M0
Treasury Stock0000000000-130.36M0
Preferred Stock0000000002.04M2.3M0

Key Metrics

Growth RegimeContracting
ProfitabilityWeak
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Capital erosion against flat assets

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Flat Assets, Shrinking Equity Base

According to CCAP's reported balance sheets, total assets held near $1.6B for ten quarters while equity fell from $751.7M to $656.5M, compressing the equity-to-assets ratio from 0.46 to 0.41 — growth appears to have stalled even as the capital base eroded.

The balance sheet has been static in scale but deteriorating in quality: assets oscillated between $1.6B and $1.7B with no discernible trend, while roughly $95M of equity disappeared, implying the franchise is consuming capital rather than compounding it. For a BDC, a flat asset base paired with falling equity suggests portfolio rotation and markdowns rather than organic origination growth, and the 2026Q2 $42.7M net portfolio rotation should be assessed against whether it is rebuilding yield or defensively shrinking risk.

Provisions Break the Reserve Hiatus

Based on CCAP's financial statements, loan loss provisions of $7.3M and $8.6M in 2026Q1 and 2026Q2 followed six quarters of nil reserves, suggesting management now recognizes credit deterioration previously unreserved against a $1.6B asset base.

The shift from zero reserves for six consecutive quarters to a $15.9M semiannual build is the clearest evidence that the credit posture has changed, and this reserve recognition directly compresses the earnings base available to fund distributions. Because the supplied data does not disclose loan-level concentration, the pace of provisioning relative to the prior no-provision regime warrants further investigation as a possible signal of sector or single-name stress that had not been formally reserved.

Loss Buffer Thins to 41% of Assets

As reported in CCAP's filings, equity declined 12.7% from $751.7M to $656.5M over ten quarters even as total assets stayed near $1.6B, implying retained losses and distributions are consuming capital faster than the balance sheet can regenerate it.

The compression from 0.46 to 0.41 of assets narrows the loss-absorption cushion, which for a BDC translates directly into reduced headroom against portfolio markdowns before net asset value is meaningfully impaired. That the equity drawdown accelerated in 2026 — the same quarters provisions resumed and NII turned negative — suggests capital is being eroded by earnings weakness rather than returned through deliberate buybacks, and the $32.2M distribution in a $3.2M loss quarter appears difficult to self-fund.

Thin Cash Against a $962M Liability Stack

Per CCAP's balance sheet data, cash and bank balances fell to $15.6M in 2026Q2 against $962.4M of liabilities — roughly 1.6% coverage — suggesting liquidity may depend on portfolio maturities and periodic rotations rather than a standing reserve pool.

Cash peaked at only $26.6M during the ten-quarter window and dropped 41% in a single quarter to $15.6M, implying near-term obligations are met through securities turnover on a lumpy, event-driven cadence rather than predictable internal generation. Given that net interest margin has inverted to -0.9%, the pricing and maturity profile of funding drawn to bridge these gaps becomes a material variable, and investors should monitor whether liquidity is being sourced at costs the asset side can no longer support.

Debt Weighting Rises as Yields Invert

According to CCAP's ten-quarter data, liabilities expanded 10.8% from $868.7M to $962.4M while equity contracted to $656.5M, meaning the funding stack grew more debt-weighted precisely as net interest margin inverted to -0.9%, a mismatch that may amplify loss leverage.

The non-obvious balance sheet risk is that leverage has increased into a negative spread environment, so each incremental dollar of liabilities appears to be dilutive rather than accretive to the equity holder — the opposite of the usual case for a leveraged credit vehicle. This structural mismatch warrants further investigation: the supplied data does not disclose the maturity ladder or repricing terms of the $962.4M liability stack, and refinancing these obligations at prevailing rates could pressure the already compressed 0.41 equity-to-assets buffer further.

CCAP — Frequently Asked Questions

Quick answers to the most common questions about buying CCAP stock.

What are the total assets of Crescent Capital BDC, Inc. (CCAP)?

As of 2025, Crescent Capital BDC, Inc. (CCAP) had total assets of $1.62B including $5.0M in current assets.

How much debt does Crescent Capital BDC, Inc. (CCAP) have?

Crescent Capital BDC, Inc. (CCAP) carries total debt of $873.8M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Crescent Capital BDC, Inc.?

Crescent Capital BDC, Inc. (CCAP) has total shareholders' equity (book value) of $706.0M ($19.06 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Crescent Capital BDC, Inc.'s current ratio and liquidity?

Crescent Capital BDC, Inc. (CCAP) reported a current ratio of 0.14x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.